Ally Bridge Group Capital Partners II, L.P. is 10% Owner at Sorrento Therapeutics, Inc. (SRNE). They have made 1 open-market trade across 1 company since 2018, most recently 2018-02-05.
CIK 0001609313
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SRNE | 1,310,588 | $403K |
Shares reported on the most recent Form 4, priced at the 2018-02-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SRNE | SELL | 2018-02-05 | 2018-02-07 | $8.00 | $566K | +21.4% | +9.7% | -4.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.